Mitsubishi UFJ Asset Management UK Ltd. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 86.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 200 shares of the healthcare conglomerate’s stock after selling 1,300 shares during the quarter. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in UnitedHealth Group were worth $105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also modified their holdings of UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the 4th quarter worth $26,000. Bayforest Capital Ltd lifted its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new stake in UnitedHealth Group in the 4th quarter worth $41,000. Finally, Copia Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter worth $42,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have commented on UNH shares. Deutsche Bank Aktiengesellschaft decreased their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research note on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research note on Monday, May 19th. TD Securities reissued a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Finally, Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and an average price target of $366.52.
UnitedHealth Group Price Performance
Shares of UNH opened at $271.92 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a 50 day moving average price of $289.37 and a 200-day moving average price of $401.34. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $246.27 billion, a PE ratio of 11.78, a PEG ratio of 1.69 and a beta of 0.43.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the previous year, the company earned $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.3%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.28% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- 3 REITs to Buy and Hold for the Long Term
- 3 Companies That Will Profit From Trump’s Semiconductor Tariffs
- How to start investing in penny stocks
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
- How to Invest in the FAANG Stocks
- Amazon’s Bears Have Raised the White Flag—Get Excited
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.